We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,536 results
  1. Atenolol

    Reference work entry 2024
  2. Quantification of Compatibility Between Polymeric Excipients and Atenolol Using Principal Component Analysis and Hierarchical Cluster Analysis

    An important challenge to overcome in the solid dosage forms technology is the selection of the most biopharmaceutically efficient polymeric...

    Barbara Rojek, Maria Gazda, Marek Wesolowski in AAPS PharmSciTech
    Article Open access 19 November 2021
  3. Comparative cardioprotective effects of carvedilol versus atenolol in a rat model of cardiorenal syndrome type 4

    The incidence of chronic kidney disease is escalating; cardiorenal syndrome (CRS) type 4 is gaining a major health concern causing significant...

    Rasha M. S. M. Mohamed, Shimaa M. Elshazly, ... Dalia M. Abd El Motteleb in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 16 August 2021
  4. Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy

    Background

    The survival rate of patients with pancreatic cancer is low; therefore, continuous discovery and development of novel pancreatic cancer...

    Adam Hermawan, Herwandhani Putri, Rohmad Yudi Utomo in DARU Journal of Pharmaceutical Sciences
    Article 23 October 2020
  5. Single-cell Sequence Analysis Combined with Multiple Machine Learning to Identify Markers in Sepsis Patients: LILRA5

    Sepsis is a disease with a very high mortality rate, mainly involving an immune-dysregulated response due to bacterial infection. Most studies are...

    **gyuan Ning, **aoqing Fan, ... Cuiqing Ma in Inflammation
    Article 15 March 2023
  6. Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved

    Nebivolol could prevent dysfunction in patients suffering myocardial ischemia. However, influence of hyperthyroidism is not known. Consequences and...

    María Inés Ragone, Matías Bayley, ... Alicia E. Consolini in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 25 October 2023
  7. β1- and β12-adrenergic receptor antagonists block 6-nitrodopamine-induced contractions of the rat isolated epididymal vas deferens

    6-Nitrodopamine (6-ND) is an endogenous modulator of the contractility in the rat isolated epididymal vas deferens (RIEVD) and considered to be the...

    Antonio Tiago Lima, Amanda Consulin Amorim, ... Gilberto De Nucci in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 July 2022
  8. The role of the peripheral and central adrenergic system in the construction of the subjective emotional experience of panic

    Rationale

    Although the study of emotions can look back to over 100 years of research, it is unclear which information the brain uses to construct the...

    Jette H. de Vos, Koen R. J. Schruers, ... Nicole K. Leibold in Psychopharmacology
    Article Open access 16 February 2024
  9. Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway

    Purpose

    To compare the co-prescription of metoprolol and potent CYP2D6-inhibiting antidepressants before and during a 10-year period after...

    Ane Gedde-Dahl, Olav Spigset, Espen Molden in European Journal of Clinical Pharmacology
    Article Open access 25 July 2022
  10. Characterization of critical parameters using an air–liquid interface model with RPMI 2650 cells for permeability studies of small molecules

    The field of nasal drug delivery gained enormously on interest over the past decade. Performing nasal in vivo studies is expensive and...

    Lea-Adriana Barlang, Kristina Weinbender, ... Andreas Popp in Drug Delivery and Translational Research
    Article 17 November 2023
  11. Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease

    Background

    Chronic Obstructive Pulmonary Disease is characterised by declining lung function and a greater oxidative stress burden due to reduced...

    Jack L. Janetzki, Nicole L. Pratt, ... Matthew J. Sykes in Pharmaceutical Research
    Article Open access 12 May 2023
  12. Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17

    Background

    Diabetes Mellitus (DM) is a prominent health care issue worldwide. One of the most prevalent comorbidities of DM is cardiovascular disease...

    Negin Hatami, Mohammad-Reza Malekpour, ... Fatemeh Soleymani in DARU Journal of Pharmaceutical Sciences
    Article 17 October 2023
  13. Influence of osmolality on gastrointestinal fluid volume and drug absorption: potential impact on oral salt supplementation

    Background

    The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is the most frequent cause of hyponatremia in patients with...

    Miyuki Takemura, Yuki Tanaka, ... Yoshiyuki Shirasaka in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 01 September 2021
  14. Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity

    Abstract

    Preclinical and early clinical mechanistic studies of antitumor activity from the beta-adrenergic receptor (β-AR) blocker propranolol have...

    Wei Li, Jielin Wan, ... Yi**g He in Journal of Molecular Medicine
    Article 27 July 2022
  15. Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020

    Purpose

    Affordable access to quality medicines is a critical target of global efforts to achieve universal health coverage. The aim of this study is...

    Fatemeh Kokabisaghi, Amir Hashemi-Meshkini, ... Javad Moghri in DARU Journal of Pharmaceutical Sciences
    Article 17 November 2022
  16. α1-adrenergic receptors accompanied by GATA4 expression are related to proarrhythmic conduction and automaticity in rat interatrial septum

    The development of interatrial septum (IAS) is a complicated process, which continues during postnatal life. The hypertrophic signals in develo**...

    Ksenia B. Pustovit, Daria V. Samoilova, ... Vladislav S. Kuzmin in Journal of Physiology and Biochemistry
    Article 08 July 2022
  17. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

    Background

    Genome-wide association studies (GWAS) have identified numerous susceptibility loci for Alzheimer’s disease (AD). However, utilizing GWAS...

    Jiansong Fang, Pengyue Zhang, ... Feixiong Cheng in Alzheimer's Research & Therapy
    Article Open access 10 January 2022
  18. The role of adrenergic and muscarinic receptors in stress-induced cardiac injury

    Takotsubo syndrome (TS) is a rare but dangerous disease that can be fatal. The pathogenesis of TS is not well understood because there is no animal...

    Boris K. Kurbatov, Ekaterina S. Prokudina, ... Peter R. Oeltgen in Pflügers Archiv - European Journal of Physiology
    Article 10 July 2021
  19. Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment

    Purpose

    The purpose of this research is to analyze non-linear pharmacokinetics of P-glycoprotein (P-gp) substrates in a cell based assay of a...

    Fumihiko Igarashi, Toshito Nakagawa, ... Tatsuhiko Tachibana in Pharmaceutical Research
    Article 19 May 2021
  20. Three Days of Chronic Intermittent Hypoxia Induce β1-Adrenoceptor Dependent Increases in Left Ventricular Contractility

    Sleep apnea is characterized by bouts of chronic intermittent hypoxia (CIH) that elicit sympathetic hyperactivity resulting in residual hypertension....
    Anthony L. Marullo, Eric F. Lucking, ... Ken D. O’Halloran in Arterial Chemoreceptors
    Conference paper 2023
Did you find what you were looking for? Share feedback.